Does GLICLAZIDE Cause Psychomotor hyperactivity? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Psychomotor hyperactivity have been filed in association with GLICLAZIDE. This represents 0.2% of all adverse event reports for GLICLAZIDE.
11
Reports of Psychomotor hyperactivity with GLICLAZIDE
0.2%
of all GLICLAZIDE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From GLICLAZIDE?
Of the 11 reports, 10 (90.9%) required hospitalization, and 10 (90.9%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLICLAZIDE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does GLICLAZIDE Cause?
Hypoglycaemia (756)
Nausea (596)
Acute kidney injury (553)
Drug ineffective (507)
Fall (415)
Dyspnoea (400)
Vomiting (385)
Lactic acidosis (373)
Malaise (360)
Hypertension (351)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which GLICLAZIDE Alternatives Have Lower Psychomotor hyperactivity Risk?
GLICLAZIDE vs GLIMEPIRIDE
GLICLAZIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLICLAZIDE vs GLIPIZIDE
GLICLAZIDE vs GLIVEC
GLICLAZIDE vs GLOFITAMAB